Hyperliquid Strategies, Inc. (PURR)
8.31
-0.39
(-4.48%)
USD |
NASDAQ |
Nov 16, 16:00
8.22
-0.09
(-1.08%)
After-Hours: 20:00
Hyperliquid Strategies Price : 8.31 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 8.14 | 8.405 | 8.00 | 8.31 | 16.53M |
| Nov 13, 2026 | 9.00 | 9.07 | 8.58 | 8.70 | 11.06M |
| Nov 12, 2026 | 8.42 | 9.05 | 8.41 | 8.805 | 9.834M |
| Nov 11, 2026 | 8.98 | 9.22 | 8.725 | 9.15 | 10.26M |
| Nov 10, 2026 | 8.57 | 8.93 | 8.47 | 8.75 | 9.833M |
| Nov 09, 2026 | 8.47 | 9.155 | 8.445 | 8.91 | 13.35M |
| Nov 06, 2026 | 8.96 | 9.26 | 8.525 | 8.815 | 10.77M |
| Nov 05, 2026 | 9.11 | 9.145 | 7.99 | 8.76 | 28.37M |
| Nov 04, 2026 | 9.99 | 10.48 | 9.495 | 9.69 | 18.93M |
| Nov 03, 2026 | 9.98 | 10.50 | 9.89 | 10.16 | 14.61M |
| Nov 02, 2026 | 10.80 | 10.98 | 9.68 | 9.71 | 17.18M |
| Oct 30, 2026 | 11.52 | 11.58 | 10.59 | 11.01 | 30.83M |
| Oct 29, 2026 | 11.28 | 12.33 | 10.77 | 12.29 | 60.52M |
| Oct 28, 2026 | 9.80 | 9.985 | 9.42 | 9.97 | 9.502M |
| Oct 27, 2026 | 9.174 | 10.07 | 9.174 | 9.85 | 11.18M |
| Oct 26, 2026 | 8.735 | 9.325 | 8.60 | 9.07 | 8.508M |
| Oct 23, 2026 | 8.60 | 8.995 | 8.55 | 8.78 | 11.26M |
| Oct 22, 2026 | 8.96 | 9.14 | 8.47 | 8.68 | 14.26M |
| Oct 21, 2026 | 9.50 | 9.85 | 9.22 | 9.62 | 10.38M |
| Oct 20, 2026 | 8.80 | 9.54 | 8.80 | 9.15 | 11.91M |
| Oct 19, 2026 | 9.26 | 9.364 | 8.95 | 8.97 | 7.521M |
| Oct 16, 2026 | 9.61 | 9.73 | 8.98 | 9.07 | 11.77M |
| Oct 15, 2026 | 9.00 | 9.845 | 8.954 | 9.80 | 13.26M |
| Oct 14, 2026 | 9.92 | 10.10 | 9.465 | 9.47 | 11.84M |
| Oct 13, 2026 | 10.15 | 10.34 | 10.11 | 10.23 | 12.90M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Strive, Inc. (United States) | 18.81 |
| Meridian Holdings, Inc. (California) | 0.0071 |
| ACADIA Pharmaceuticals, Inc. | 18.67 |
| Agenus, Inc. | 6.29 |
| Alnylam Pharmaceuticals, Inc. | 159.73 |
Price Related Metrics
| PE Ratio | 2.596 |
| PS Ratio | 63.76 |
| Price to Book Value | 0.6654 |
| Earnings Yield | 38.52% |
| Market Cap | 2.264B |
| Operating PE Ratio | 8142.64 |